Oslo, Norway, 13 August 2026
Vistin Pharma ASA (VISTN) will release its second quarter and YTD 2026 results
on Thursday 20th of August 2026. Vistin Pharma will host a conference call for
all shareholders and other interested parties on the same day at 08:30 CET.
There will be a Q&A session following the management discussion.
The second quarter conference call will be accessible via web and audio through
the following access points:
Webcast: https://edge.media-server.com/mmc/p/abe93pzc
Telephone conference (online registration):
https://register-conf.media-
server.com/register/BIca3298faa94f4bbb900f07289bc40eb7 (https://register-
conf.media-server.com/register/BI83c6eca2da3d47c3bec047d0633a0501)
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.
icated manufacturing facility in Kragerø.\